Literature DB >> 7438326

Distribution of Bratton-Marshall-positive material in mice following intravenous injections of nitrosoureas.

P Kari, W R McConnell, J M Finkel, D L Hill.   

Abstract

As determined by a colorimetric assay measuring parent compounds plus ether-extractable nitroso-containing metabolites, N,N'-bis(2-chloroethyl)-N-nitrosourea (BCNU) disappeared more rapidly than N-(2-chloroethyl)-N'cyclohexyl-N-nitrosourea (CCNU) and N-(2-chloroethyl)-N'-(4-transmethylcyclohexyl)-N-nitrosourea (MeCCNU) and their products from the tissues of mice injected IV. Assay of selected samples by high-pressure liquid chromatography revealed that the colorimetric assay for BCNU was specific in that the two assays gave equivalent results. Following IV-injections of CCNU and MeCCNU, however, levels of the parent compounds decreased much more rapidly than the total, color-producing material. Of seven tissues, the largest Cxt values for BCNU, as determined by the colorimetric assay, were noted for blood (442 microgram-min/ml) and large intestine (285 microgram-min/g). Liver (29 microgram-min/g) had the lowest Cxt value, reflecting rapid metabolism of the compound by this organ. Color-producing material related to CCNU disappeared from the solid tissues of mice in a manner generally parallel to that for blood. Of the Cxt values for this compound and its products, those for lung (1753 microgram-equivalents-min/g), kidney (1633 microgram-equivalents-min/g), and small intestine (1557 microgram-equivalents-min/g) were highest. Consistent with its slower rate of metabolism, MeCCNU and its color-producing metabolites remained in most tissues of mice for 12 h following injection. Except for brain (1434 microgram-equivalents-min/g), Cxt values for this nitrosourea and its metabolites in tissues were higher than those of blood (5485 microgram-equivalents-min/ml), with kidney (15,324 micrograms-equivalents-min/g), liver (12,921 microgram-equivalents-min/g), and large intestine (11,501 microgram-equivalents-min/g) being highest. For each nitrosourea, a fair correlation was observed between the Cxt values for tissues and the toxic and/or antitumor effects at those sites.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438326     DOI: 10.1007/bf00255268

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  30 in total

1.  Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia.

Authors:  F M SCHABEL; T P JOHNSTON; G S McCALEB; J A MONTGOMERY; W R LASTER; H E SKIPPER
Journal:  Cancer Res       Date:  1963-06       Impact factor: 12.701

2.  Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.

Authors:  E P Denine; S D Harrison; J C Peckham
Journal:  Cancer Treat Rep       Date:  1977 May-Jun

3.  Chronic renal failure in children treated with methyl CCNU.

Authors:  W E Harmon; H J Cohen; E E Schneeberger; W E Grupe
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

4.  Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.

Authors:  J G Mayo; W R Laster; C M Andrews; F M Schabel
Journal:  Cancer Chemother Rep       Date:  1972-04

5.  Formulation of three nitrosoureas for intravenous use.

Authors:  J P Davignon; K W Yang; H B Wood; J C Cradock
Journal:  Cancer Chemother Rep 3       Date:  1973-05

6.  The physiological disposition of the carcinostatic 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in man and animals.

Authors:  V T DeVita; C Denham; J D Davidson; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1967 Jul-Aug       Impact factor: 6.875

7.  Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.

Authors:  V A Levin; P A Kabra; M A Freeman-Dove
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

8.  The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.

Authors:  V A Levin; J Stearns; A Byrd; A Finn; R J Weinkam
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

9.  Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes.

Authors:  H E May; R Boose; D J Reed
Journal:  Biochem Biophys Res Commun       Date:  1974-03-25       Impact factor: 3.575

10.  Physiologic disposition of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (Me CCNU) in man.

Authors:  R W Sponzo; V T DeVita; V T Oliverio
Journal:  Cancer       Date:  1973-05       Impact factor: 6.860

View more
  4 in total

1.  Clinical pharmacokinetics of oral CCNU (lomustine).

Authors:  F Y Lee; P Workman; J T Roberts; N M Bleehen
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

2.  Distribution of 13N in rat tissues following intravenous administration of nitroso-labeled BCNU.

Authors:  B R Freed; R L McQuinn; R S Tilbury; G A Digenis
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

3.  Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.

Authors:  Grace Y Kim; Betty M Tyler; Malinda M Tupper; Jeffrey M Karp; Robert S Langer; Henry Brem; Michael J Cima
Journal:  J Control Release       Date:  2007-08-15       Impact factor: 9.776

4.  BCNU stability as a function of ethanol concentration and temperature.

Authors:  P Tepe; S J Hassenbusch; R Benoit; J H Anderson
Journal:  J Neurooncol       Date:  1991-04       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.